glp-1 agonists long term effects Weight loss medications like Ozempic, Wegovy, and Mounjaro are not harmless. They come with risks—muscle loss, malnutrition, nausea, vomiting, gastroparesis stomach paralysis), pancreatitis, gallbladder disease, increased thyroid cancer risk, poor Research shows most people regain

The bottom line: Our findings suggest that GLP-1RA and SGLT2i (and especially SGLT2i with the lowest number needed to treat (NNT) for nearly all study outcomes) may be the preferred glucose-lowering agents for cardiovascular risk reduction in patients at moderate risk for CVD, building on and consistent with existing RCT evidence in the high-risk population. This report highlights potential preference for GLP-1 drugs as a first-line treatment for Type 2 diabetes related to its cardioprotective effect

doi: 10.1007/978-981-10-5311-5_20

doi: 10.1176/ajp.156.11.1686 122

In the absence of a peak during the interval time, no peak time was recorded

doi: 10.1097/MIB.0000000000000955 65 Gomez-BrisRSaezAHerrero-FernandezBRiusCSanchez-MartinezHGonzalez-GranadoJM